CPAY vs FISV
Corpay vs Fiserv — AI-powered side-by-side comparison
| Metric | CPAY | FISV |
|---|
| AI Score |
70
|
58
|
| Price |
$409.27
|
$52.60
|
| P/E Ratio |
24.86×
|
10.15×
|
| ROE |
27.5%
|
13.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
73.3%
|
47.2%
|
| Debt / Equity |
3.00×
|
1.04×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
61.0
|
51.9
|
| Beta |
0.869
|
0.798
|
| Expected Upside |
—
|
+21.8%
|
AI Committee View
Current Innellis committee reasoning for CPAY versus FISV.
CPAY leads by 12 points.
CPAY scores 70/100 (Buy) versus FISV at 58/100 (Buy).
CPAY Committee View
100% agreement
4 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical
- Weekly RSI at 79 -- overbought on the larger timeframe too — Technical
FISV Committee View
40% agreement
5 analysts
The committee is genuinely divided. Value Analyst sees a compelling case — p/e of 10.0 is inexpensive for the broad market. Growth Analyst remains cautious — revenue declining -1.2% yoy -- this is not a growth story right now. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- P/E of 10.0 is inexpensive for the broad market — Value
- Price-to-book of 1.4x is a discount to asset value — Value
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
- Revenue declining -1.2% YoY -- this is not a growth story right now — Growth
- EPS declining -12.9% YoY despite any revenue growth — Growth
- Price structure making lower highs and lower lows — Technical